SEC Info℠ | Home | Search | My Interests | Help | Sign In | Please Sign In | ||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size 3/06/18 American Renal Assocs Holdin… Inc 10-K 12/31/17 109:11M |
Document/Exhibit Description Pages Size 1: 10-K Annual Report HTML 1.63M 2: EX-10.11 Material Contract HTML 43K 3: EX-21.1 Subsidiaries List HTML 90K 4: EX-23.1 Consent of Experts or Counsel HTML 27K 5: EX-31.1 Certification -- §302 - SOA'02 HTML 35K 6: EX-31.2 Certification -- §302 - SOA'02 HTML 35K 7: EX-32.1 Certification -- §906 - SOA'02 HTML 30K 8: EX-32.2 Certification -- §906 - SOA'02 HTML 30K 15: R1 Document and Entity Information HTML 55K 16: R2 Consolidated Balance Sheets HTML 121K 17: R3 Consolidated Balance Sheets (Parenthetical) HTML 46K 18: R4 Consolidated Statements of Operations HTML 98K 19: R5 Consolidated Statements of Comprehensive Income HTML 42K 20: R6 Consolidated Statements of Changes in Equity HTML 126K 21: R7 Consolidated Statements of Changes in Equity HTML 31K (Parenthetical) 22: R8 Consolidated Statements of Cash Flows HTML 166K 23: R9 Basis of Presentation and Organization HTML 34K 24: R10 Summary of Significant Accounting Policies HTML 93K 25: R11 Initial Public Offering HTML 50K 26: R12 Cash HTML 34K 27: R13 Prepaid Expenses and Other Current Assets HTML 36K 28: R14 Acquisitions HTML 45K 29: R15 Fair Value Measurements HTML 102K 30: R16 Property and Equipment HTML 44K 31: R17 Intangible Assets and Goodwill HTML 57K 32: R18 Accrued Expenses and Other Current Liabilities HTML 43K 33: R19 Variable Interest Entities HTML 36K 34: R20 Noncontrolling Interests Subject to Put Provisions HTML 59K 35: R21 Changes in Ownership Interest in Consolidated HTML 45K Subsidiaries 36: R22 Debt HTML 76K 37: R23 Leases HTML 53K 38: R24 Income Taxes HTML 101K 39: R25 Earnings (Loss) Per Share HTML 69K 40: R26 Equity HTML 34K 41: R27 Stock-Based Compensation HTML 113K 42: R28 Related Party Transactions HTML 47K 43: R29 Commitments and Contingencies HTML 36K 44: R30 Certain Legal Matters HTML 47K 45: R31 Employee Benefit Plan HTML 30K 46: R32 Concentrations HTML 32K 47: R33 Selected Quarterly Financial Data (Unaudited) HTML 76K 48: R34 Subsequent Event HTML 30K 49: R35 Schedule Ii - Valuation and Qualifying Accounts HTML 45K 50: R36 Summary of Significant Accounting Policies HTML 138K (Policies) 51: R37 Summary of Significant Accounting Policies HTML 31K (Tables) 52: R38 Cash (Tables) HTML 33K 53: R39 Prepaid Expenses and Other Current Assets (Tables) HTML 36K 54: R40 Acquisitions (Tables) HTML 37K 55: R41 Fair Value Measurements (Tables) HTML 98K 56: R42 Property and Equipment (Tables) HTML 43K 57: R43 Intangible Assets and Goodwill (Tables) HTML 59K 58: R44 Accrued Expenses and Other Current Liabilities HTML 44K (Tables) 59: R45 Noncontrolling Interests Subject to Put Provisions HTML 53K (Tables) 60: R46 Changes in Ownership Interest in Consolidated HTML 46K Subsidiaries (Tables) 61: R47 Debt (Tables) HTML 57K 62: R48 Leases (Tables) HTML 47K 63: R49 Income Taxes (Tables) HTML 99K 64: R50 Earnings (Loss) Per Share (Tables) HTML 67K 65: R51 Stock-Based Compensation (Tables) HTML 100K 66: R52 Selected Quarterly Financial Data (Unaudited) HTML 75K (Tables) 67: R53 Basis of Presentation and Organization (Details) HTML 42K 68: R54 Summary of Significant Accounting Policies HTML 96K (Details) 69: R55 Initial Public Offering (Details) HTML 124K 70: R56 Cash (Details) HTML 37K 71: R57 Prepaid Expenses and Other Current Assets HTML 34K (Details) 72: R58 Acquisitions (Details) HTML 53K 73: R59 Fair Value Measurements - Narrative (Details) HTML 40K 74: R60 Fair Value Measurements - Schedule of fair value HTML 85K (Details) 75: R61 Fair Value Measurements - Fair value rollforward HTML 37K of tax receivable agreement liability (Details) 76: R62 Property and Equipment (Details) HTML 50K 77: R63 Intangible Assets and Goodwill - Schedule of HTML 52K intangible assets (Details) 78: R64 Intangible Assets and Goodwill - Estimated annual HTML 44K amortization expense (Details) 79: R65 Intangible Assets and Goodwill - Changes in the HTML 38K value of goodwilll (Details) 80: R66 Accrued Expenses and Other Current Liabilities HTML 45K (Details) 81: R67 Variable Interest Entities (Details) HTML 32K 82: R68 Noncontrolling Interests Subject to Put Provisions HTML 61K (Details) 83: R69 Changes in Ownership Interest in Consolidated HTML 45K Subsidiaries (Details) 84: R70 Debt - Schedule of long term-term debt (Details) HTML 56K 85: R71 Debt - Narrative (Detail) HTML 126K 86: R72 Debt Debt - Scheduled maturities of long-term debt HTML 47K (Details) 87: R73 Leases (Details) HTML 47K 88: R74 Leases - Schedule of Future Minimum Lease Payments HTML 82K (Details) 89: R75 Income Taxes - Provision (Benefit) for Income HTML 48K Taxes (Details) 90: R76 Income Taxes - Significant components of deferred HTML 67K tax assets and liabilities (Details) 91: R77 Income Taxes Income Taxes - Narrative (Details) HTML 37K 92: R78 Income Taxes - Reconciliation of the federal HTML 51K statutory rate (Details) 93: R79 Earnings (Loss) Per Share (Details) HTML 68K 94: R80 Equity (Details) HTML 50K 95: R81 Stock-Based Compensation - Narrative (Details) HTML 61K 96: R82 Stock-Based Compensation - Equity Grants, HTML 35K Assumptions and Activity (Details) 97: R83 Stock-Based Compensation - Assumptions used for HTML 50K options granted (Details) 98: R84 Stock-Based Compensation - Stock option activity HTML 94K (Details) 99: R85 Stock-Based Compensation - Restricted stock HTML 62K activity (Details) 100: R86 Related Party Transactions (Details) HTML 87K 101: R87 Commitments and Contingencies (Details) HTML 35K 102: R88 Certain Legal Matters (Details) HTML 52K 103: R89 Employee Benefit Plan (Details) HTML 29K 104: R90 Concentrations (Details) HTML 28K 105: R91 Selected Quarterly Financial Data (Unaudited) HTML 51K (Details) 106: R92 Schedule Ii - Valuation and Qualifying Accounts HTML 37K (Details) 108: XML IDEA XML File -- Filing Summary XML 189K 107: EXCEL IDEA Workbook of Financial Reports XLSX 126K 9: EX-101.INS XBRL Instance -- ara-20171231 XML 2.46M 11: EX-101.CAL XBRL Calculations -- ara-20171231_cal XML 342K 12: EX-101.DEF XBRL Definitions -- ara-20171231_def XML 725K 13: EX-101.LAB XBRL Labels -- ara-20171231_lab XML 2.22M 14: EX-101.PRE XBRL Presentations -- ara-20171231_pre XML 1.28M 10: EX-101.SCH XBRL Schema -- ara-20171231 XSD 218K 109: ZIP XBRL Zipped Folder -- 0001498068-18-000012-xbrl Zip 306K
Exhibit |
1. | I have reviewed this Annual Report on Form 10-K for the year ended December 31, 2017 of American Renal Associates Holdings, Inc. (the “registrant”); |
2. | Based
on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; |
3. | Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report; |
4. | The
registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have: |
(a) | Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries,
is made known to us by others within those entities, particularly during the period in which this report is being prepared; |
(b) | Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; |
(c) | Evaluated the effectiveness of the
registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and |
(d) | Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially
affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and |
5. | The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
|
(a) | All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and |
(b) | Any fraud, whether or not material, that involves management or other employees who have a significant role in the
registrant’s internal control over financial reporting. |
Chief Financial Officer |
This ‘10-K’ Filing | Date | Other Filings | ||
---|---|---|---|---|
Filed on: | 3/6/18 | 8-K | ||
For Period end: | 12/31/17 | |||
List all Filings |